Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial. (Record no. 29760434)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02874 a2200841 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518042832.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202006s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1474-5488 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/S1470-2045(19)30151-2 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Rozeman, Elisa A |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20200622 |
| 245 00 - TITLE STATEMENT | |
| Title | Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The Lancet. Oncology |
| Date of publication, distribution, etc. | 07 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 948-960 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adolescent |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents, Immunological |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Administration Schedule |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ipilimumab |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Melanoma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoadjuvant Therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Staging |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nivolumab |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Skin Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Menzies, Alexander M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van Akkooi, Alexander C J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Adhikari, Chandra |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bierman, Carolien |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van de Wiel, Bart A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Scolyer, Richard A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Krijgsman, Oscar |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sikorska, Karolina |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Eriksson, Hanna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Broeks, Annegien |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van Thienen, Johannes V |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Guminski, Alexander D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Acosta, Alex Torres |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ter Meulen, Sylvia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Koenen, Anne Miek |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bosch, Linda J W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shannon, Kerwin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pronk, Loes M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gonzalez, Maria |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ch'ng, Sydney |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Grijpink-Ongering, Lindsay G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Stretch, Jonathan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Heijmink, Stijn |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van Tinteren, Harm |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Haanen, John B A G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nieweg, Omgo E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Klop, Willem M C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zuur, Charlotte L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Saw, Robyn P M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van Houdt, Winan J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Peeper, Daniel S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Spillane, Andrew J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hansson, Johan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schumacher, Ton N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Long, Georgina V |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Blank, Christian U |
| 773 0# - HOST ITEM ENTRY | |
| Title | The Lancet. Oncology |
| Related parts | vol. 20 |
| -- | no. 7 |
| -- | p. 948-960 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/S1470-2045(19)30151-2">https://doi.org/10.1016/S1470-2045(19)30151-2</a> |
| Public note | Available from publisher's website |
No items available.